Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025. The Company also reminds those who have previously voted ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an FDA-approved treatment.

Australia is facing some of the biggest challenges in our history: climate change, food security, energy transition, and the ...

The quadrivalent recombinant influenza vaccine is as safe and immunogenic in children and adolescents aged 9-17 years as it ...

Nervous necrosis virus typically enters host cells via endocytosis, but it can also enter via a process called macropinocytosis.

Industrial fermentation using bacteria, yeast and other microbes to produce specific products has the potential to reduce ...

Patients with persistent fish allergy and parvalbumin sensitization had a low threshold for reactions, which were severe, ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025. The Company also reminds those who have previously voted ...

As we enter the colder months in Australia, COVID is making headlines again, this time due to the emergence of a new variant: ...

The use of the recombinant influenza vaccine can prevent a substantial number of influenza-related hospitalizations among ...